| ABSTRACT:
Age-related macular degeneration (AMD), a disorder of the retinal pigment epithelium, is the leading cause of blindness for people aged 65 and older. Due to an aging population, the number of AMD cases is expected to triple in the next 25 to 40 years. There is, as yet no cure for this disease. The Age-Related Eye Disease Study (AREDS) was the first large clinical trial to investigate the effect of high-dose ocular supplementation on progression of AMD... |
Author(s):
John Jantzi, OD
Company: Mediconcepts, Inc
Expire Date: 04/01/2006
CE Credits: 1
Price: $20.00
CE Format: PDF
COPE ID: 9448-PS
|